The MD transcriptome included high expression of Alzheimer’s disease risk genes (App, Mapt, Bace1, Apoe) and the nerve growth factor (NGF) receptor (Ngfr) (Supplemental Figure 3C). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.